Honors & Recognition

BD HealthSight™ Clinical Advisor and BD HealthSight™ Infection Advisor with MedMined™ Insights earns Meaningful Use Stage 3 certification for antimicrobial use and resistance reporting



BD HealthSight Clinical Advisor and BD HealthSight™ Infection Advisor with MedMined Insights (formerly MedMined Surveillance Advisor) has earned Meaningful Use Stage 3 (MU3) certification validating its ability to collect and properly report data around antimicrobial use and resistance data by facilities enrolled in the National Healthcare Safety Network (NHSN) that requires reporting for Antimicrobial Use and Resistance (AUR) data in 2022.

Public Health Registry Reporting is a new option for MU3, requiring AUR data to help the Centers for Disease Control and Prevention (CDC) to gain a better understanding of how antibiotic usage impacts resistance in hospitals and healthcare facilities. The objective calls for reporting a full calendar year's data on R1 Normative Antimicrobial Use Summary, Antimicrobial Resistance Event, and Antimicrobial Resistance summary data to be reported using clinical documentation architecture (CDA) formatting.

By submitting AUR data into the NHSN platform, clinicians can benchmark their antibiotic usage and organism resistance data nationally to target areas for improvement.

By leveraging data from a hospital's electronic medical record, physician order entry, laboratory and pathology systems to monitor patients for adverse drug events and interactions, BD HealthSight Clinical Advisor and BD HealthSight™ Infection Advisor with MedMined Insights can alert clinicians and pharmacists and identify opportunities for antimicrobial stewardship across the continuum of care.



"This Health IT Module is 2015 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services."

This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

Additional Costs:

This certified product-version is certified to data export criteria 170.315(f)(6) and can generate Antimicrobial Use and Resistance CDA reports. This certified product version requires an annual licensing fee and may require a one-time implementation fee.

Certification Information

Vendor Name:
Becton, Dickinson and Company
3750 Torrey View Ct, San Diego California 92130

Kim Nguyen
Phone: +1 760.484.4799
Website:  BD HealthSight™ Enterprise Pharmacy Analytics Solutions

Certified Health IT Name and Version:
AUR Reporting Module, Version 1

Criteria Certified:
170.315 (d)(1), 170.315 (d)(2), 170.315 (d)(3), 170.315 (d)(7), 170.315 (d)(12), 170.315 (d)(13), 170.315 (f)(6), 170.315 (g)(4), 170.315 (g)(5)

Certification Date:

Certification ID:

Additional Software: